{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:01:02Z","timestamp":1770980462342,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,8,24]],"date-time":"2013-08-24T00:00:00Z","timestamp":1377302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s10067-013-2378-0","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T05:02:48Z","timestamp":1377234168000},"page":"273-276","source":"Crossref","is-referenced-by-count":58,"title":["Long-term safety of anti-TNF-\u03b1 in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients"],"prefix":"10.1007","volume":"33","author":[{"given":"Luisa","family":"Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Caso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Atteno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Giannitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Spadaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Ramonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maristella","family":"Vezz\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Del Puente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filomena","family":"Morisco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugo","family":"Fiocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Galeazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,24]]},"reference":[{"key":"2378_CR1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","volume":"3","author":"JM Moll","year":"1973","unstructured":"Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3:55\u201378","journal-title":"Semin Arthritis Rheum"},{"key":"2378_CR2","first-page":"1241","volume":"27","author":"R Scarpa","year":"2000","unstructured":"Scarpa R, Manguso F, D'Arienzo A, D'Armiento FP, Astarita C, Mazzacca G, Ayala F (2000) Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. J Rheumatol 27:1241\u20131246","journal-title":"J Rheumatol"},{"key":"2378_CR3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10067-011-1892-1","volume":"31","author":"L Costa","year":"2012","unstructured":"Costa L, Caso F, D'Elia L, Atteno M, Peluso R, Del Puente A, Strazzullo P, Scarpa R (2012) Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study. Clin Rheumatol 31:711\u2013715","journal-title":"Clin Rheumatol"},{"key":"2378_CR4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10067-011-1680-y","volume":"30","author":"R Scarpa","year":"2011","unstructured":"Scarpa R, Atteno M, Lubrano E, Provenzano G, D'Angelo S, Spadaro A, Costa L, Olivieri I (2011) The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study. Clin Rheumatol 30:1063\u20131067","journal-title":"Clin Rheumatol"},{"key":"2378_CR5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.autrev.2006.12.003","volume":"6","author":"L Punzi","year":"2007","unstructured":"Punzi L, Podswiadek M, Sfriso P, Oliviero F, Fiocco U, Todesco S (2007) Pathogenetic and clinical rationale for TNF-blocking therapy in psoriatic arthritis. Autoimmun Rev 6:524\u2013528","journal-title":"Autoimmun Rev"},{"key":"2378_CR6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/03009742.2012.698393","volume":"41","author":"V Modesti","year":"2012","unstructured":"Modesti V, Ramonda R, Ortolan A, Lorenzin M, Lo Nigro A, Frallonardo P, Oliviero F, Campana C, Punzi L (2012) Infection relapse in spondyloarthritis treated with biological drugs: a single-centre study. Scand J Rheumatol 41:490\u2013491","journal-title":"Scand J Rheumatol"},{"key":"2378_CR7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCG.0b013e318030e3ab","volume":"42","author":"P Fabris","year":"2008","unstructured":"Fabris P, Baldo V, Baldovin T, Bellotto E, Rassu M, Trivello R, Tramarin A, Tositti G, Floreani A (2008) Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population. J Clin Gastroenterol 42:527\u2013532","journal-title":"J Clin Gastroenterol"},{"key":"2378_CR8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.autrev.2008.05.002","volume":"8","author":"I Cavazzana","year":"2008","unstructured":"Cavazzana I, Ceribelli A, Cattaneo R, Franceschini F (2008) Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. Autoimmun Rev 8:104\u2013106","journal-title":"Autoimmun Rev"},{"key":"2378_CR9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaad.2005.05.043","volume":"54","author":"C Rokhsar","year":"2006","unstructured":"Rokhsar C, Rabhan N, Cohen SR (2006) Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection. J Am Acad Dermatol 54:361\u2013362","journal-title":"J Am Acad Dermatol"},{"key":"2378_CR10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jaad.2004.05.013","volume":"51","author":"MA Magliocco","year":"2004","unstructured":"Magliocco MA, Gottlieb AB (2004) Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases. J Am Acad Dermatol 51:580\u2013584","journal-title":"J Am Acad Dermatol"},{"key":"2378_CR11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10067-006-0394-z","volume":"26","author":"S Aslanidis","year":"2007","unstructured":"Aslanidis S, Vassiliadis T, Pyrpasopoulou A, Douloumpakas I, Zamboulis C (2007) Inhibition of TNFalpha does not induce viral reactivation in patients with chronic hepatitis C infection: two cases. Clin Rheumatol 26:261\u2013264","journal-title":"Clin Rheumatol"},{"key":"2378_CR12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ncprheum0537","volume":"3","author":"LH Calabrese","year":"2007","unstructured":"Calabrese LH, Zein N (2007) Biologic agents and liver toxicity: an added concern or therapeutic opportunity? Nat Clin Pract Rheumatol 3:422\u2013423","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2378_CR13","first-page":"S28","volume":"29","author":"Salvarani C, Olivieri I, Pipitone N, Cantini F, Marchesoni A, Punzi L, Scarpa R, Matucci-Cerinic M; Italian Society for Rheumatology","year":"2011","unstructured":"Salvarani C, Olivieri I, Pipitone N, Cantini F, Marchesoni A, Punzi L, Scarpa R, Matucci-Cerinic M; Italian Society for Rheumatology (2011) Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology. Clin Exp Rheumatol 29:S28\u2013S41","journal-title":"Clin Exp Rheumatol"},{"key":"2378_CR14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/hep.25726","volume":"56","author":"J Park","year":"2012","unstructured":"Park J, Kang W, Ryu SW, Kim WI, Chang DY, Lee DH, do Park Y, Choi YH, Choi K, Shin EC, Choi C (2012) Hepatitis C virus infection enhances TNF\u03b1-induced cell death via suppression of NF-\u03baB. Hepatology 56:831\u2013840","journal-title":"Hepatology"},{"key":"2378_CR15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1568-9972(03)00048-X","volume":"2","author":"AG Suryaprasad","year":"2003","unstructured":"Suryaprasad AG, Prindiville T (2003) The biology of TNF blockade. Autoimmun Rev 2:346\u2013357","journal-title":"Autoimmun Rev"},{"key":"2378_CR16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0016-5085(92)91122-K","volume":"103","author":"H Tilg","year":"1992","unstructured":"Tilg H, Wilmer A, Vogel W, Herold M, N\u00f6lchen B, Judmaier G, Huber C (1992) Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264\u2013274","journal-title":"Gastroenterology"},{"key":"2378_CR17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1440-1711.2001.01036.x","volume":"79","author":"AJ Freeman","year":"2001","unstructured":"Freeman AJ, Marinos G, Ffrench RA, Lloyd AR (2001) Immunopathogenesis of hepatitis C virus infection. Immunol Cell Biol 79:515\u2013536","journal-title":"Immunol Cell Biol"},{"key":"2378_CR18","first-page":"210","volume":"23","author":"E Larrea","year":"1996","unstructured":"Larrea E, Garcia N, Qian C, Civeira MP, Prieto J (1996) Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology 23:210\u2013217","journal-title":"Hepatology"},{"key":"2378_CR19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.62.5.482","volume":"62","author":"D Aletaha","year":"2003","unstructured":"Aletaha D, Kapral T, Smolen JS (2003) Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. Ann Rheum Dis 62:482\u2013486","journal-title":"Ann Rheum Dis"},{"key":"2378_CR20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1196\/annals.1423.058","volume":"1110","author":"M Galeazzi","year":"2007","unstructured":"Galeazzi M, Bellisai F, Giannitti C, Manganelli S, Morozzi G, Sebastiani GD (2007) Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection. Ann N Y Acad Sci 1110:544\u2013549","journal-title":"Ann N Y Acad Sci"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2378-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-013-2378-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2378-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:28Z","timestamp":1559120248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-013-2378-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,24]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["2378"],"URL":"https:\/\/doi.org\/10.1007\/s10067-013-2378-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,24]]}}}